ArticleBMC infectious diseases2025

Real-world effectiveness of simnotrelvir-ritonavir versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 during the omicron wave in China: a retrospective cohort study.

Chuntao Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.